Mirko Signorelli
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Dynamic prediction of survival using multivariate functional principal component analysis: A strict landmarking approach.
Journal: Statistical methods in medical research
Published: January 10, 2024
Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkers.
Journal: Clinical proteomics
Published: January 15, 2023
Multiomic characterization of disease progression in mice lacking dystrophin.
Journal: PloS one
Published: November 10, 2022
Longitudinal Assessment of Creatine Kinase, Creatine/Creatinineratio, and Myostatin as Monitoring Biomarkers in Becker Muscular Dystrophy.
Journal: Neurology
Published: January 26, 2022
Penalized regression calibration: A method for the prediction of survival outcomes using complex longitudinal and high-dimensional data.
Journal: Statistics in medicine
Published: January 25, 2021
Low dystrophin variability between muscles and stable expression over time in Becker muscular dystrophy using capillary Western immunoassay.
Journal: Scientific reports
Published: August 27, 2020
Peripheral blood transcriptome profiling enables monitoring disease progression in dystrophic mice and patients.
Journal: EMBO molecular medicine
Published: August 24, 2020
Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy.
Journal: Journal of neuromuscular diseases
Published: May 12, 2020
Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy.
Journal: Pharmacological research
Published: March 20, 2020
Evaluation of blood gene expression levels in facioscapulohumeral muscular dystrophy patients.
Journal: Scientific reports
Published: February 28, 2020
Longitudinal metabolomic analysis of plasma enables modeling disease progression in Duchenne muscular dystrophy mouse models.
Journal: Human molecular genetics
Published: October 18, 2019
Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy.
Journal: Journal of cachexia, sarcopenia and muscle
Published: April 12, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026